标题: |
代谢相关脂肪性肝病与慢性肾脏病诊治专家共识 |
title: |
Metabolic dysfunction-associated fatty liver disease and risk of CKD |
版本: |
原创版 |
version: |
Original |
分类: |
专家共识 |
classification: |
Experts consensus |
领域: |
综合 |
field: |
Comprehensive guideline |
国家和地区: |
中国 |
Country and
region:
|
China |
指南使用者: |
各级医院从事肝病、肾脏病相关工作的临床医师、护理人员及技术人员 |
Guide users:
|
Clinicians, nurses and technicians engaged in liver disease and renal disease in hospitals |
证据分级方法: |
推荐意见分级的评估、制定及评价 |
Evidence grading
method:
|
Grading of recommendations assessment, development and evaluation |
制定单位: |
国际专家小组及 CHESS-MAFLD协作组 |
Formulating unit: |
panel of International experts and CHESS-MAFLD collaboration |
注册时间: |
2022-06-22 |
Registration time: |
注册编号: |
IPGRP-2022CN359 |
Registration number: |
指南制订的目的: |
早期诊治和规范化管理MAFLD合并CKD 人群 |
Purpose of the guideline:
|
Management and treatments provide a framework for the development of appropriate guidance on CKD in patients with MAFLD |